Suchergebnisse - (Person:"Xu, Kaijin")

PubPharm (7)

1

Cost-Effectiveness of Hepatitis B Mass Screening and Management in High-Prevalent Rural China : A Model Study From 2020 to 2049

enthalten in: International journal of health policy and management | 2022

von Xu, X. | Wu, C. | Jiang, L. | +10

2

Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019

enthalten in: Journal of medical virology | 2021

von Xia, Q. | Dai, W. | Xu, K. | +22

3

Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients : An Exploratory Randomized, Controlled Trial

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2021

von Lou, Y. | Liu, L. | Yao, H. | +10

4

Disease burden of chronic hepatitis B and complications in China from 2006 to 2050 : an individual-based modeling study

enthalten in: Virology journal | 2020

von Zheng, Y. | Wu, J. | Ding, C. | +3

5

Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection : a Single-Center 28-Day Study

enthalten in: The Journal of infectious diseases | 2020

von Shi, D. | Wu, W. | Wang, Q. | +10

6

Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS

enthalten in: AIDS (London, England) | 2020

von Su, J. | Shen, X. | Ni, Q. | +7

7

The serum IL-23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2015

von Yu, C. | Gong, X. | Yang, Q. | +4

1
[1]